ENTITY
Lupin Ltd

Lupin Ltd (LPC IN)

244
Analysis
Health CareIndia
Lupin Limited manufactures bulk actives and formulations. The principal bulk actives manufactured by it include Rifampicin, Pyrazinamide, Ethambutol (anti-TB), Cephalosporins (anti-infectives) and cardiovasculars. The company also possesses competencies in phytomedicines, in which medicines are made out of plant and herbal resources supported by the discipline of modern medicine.
more
05 Jun 2024 19:02Broker

Equity Investment Strategy: Post Lok Sabha Election 2024

On 4th June 2024, three election results were due 1) Loksabha election 2024, 2) State election results of Andra pradesh, and 3) State election...

Logo
340 Views
Share
04 Jun 2024 06:45Broker

Axis Top Picks for the Month of June 2024

The Axis Top Picks Basket delivered an excellent return of 5.4% in the last three months against the 2.5% return posted by Nifty 50, thereby...

Logo
422 Views
Share
bullishLupin Ltd
10 May 2024 18:48Broker

Lupin - Niche Product Drives Earnings Growth

Motilal Oswal's research report onLupin Lupin (LPC) delivered in-line operational performance in 4QFY24. LPC ended FY24 on a strong note, with...

Logo
411 Views
Share
bullishLupin Ltd
09 May 2024 21:51Broker

Lupin (LPC IN) - Margins to Sustain

Prabhudas Lilladher's research report onLupin We revise our FY25/26E EPS estimates by 2.1%/4.3%, as we factor in higher margins.

Logo
296 Views
Share
09 May 2024 06:21Broker

HSIE Results Daily: Dr Reddy’s Laboratories, Lupin, IRB Infra, Max Financial

DRRD expects to sustain growth in the US over the next few years with steady traction in gRevlimid and new launches (20+ launches p.a for the next...

Logo
330 Views
Share
x